NASDAQ:CPXX (CPXX) (CPXX) Stock Price, News & Analysis → The Gold Grab of the Century (From Colonial Metals) (Ad) Free CPXX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$30.24▼$30.2450-Day Range N/A52-Week Range$1.12▼$30.36VolumeN/AAverage Volume2.62 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get (CPXX) alerts: Email Address Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. About (CPXX) Stock (NASDAQ:CPXX)Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company. The Company is engaged in developing products to improve patient outcomes in cancer. The Company's technology platform, CombiPlex, enables the design and evaluation of optimized combinations incorporating traditional chemotherapies, as well as molecularly targeted agents to deliver anti-cancer activity. The Company's product, VYXEOS, a nano-scale liposomal formulation of cytarabine:daunorubicin, in Phase III clinical testing for the treatment of acute myeloid leukemia. The Company also conducted clinical development efforts on CPX-1, a nano-scale liposomal formulation of irinotecan:floxuridine for the treatment of colorectal cancer; and has a preclinical stage product candidate CPX-8, a hydrophobic docetaxel prodrug nanoparticle formulation. The Company operates in the United States and Canada.Read More Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. CPXX Stock News HeadlinesJune 21, 2023 | msn.comUkraine Inches Towards Russian Stronghold as Counteroffensive Pushes OnJune 21, 2023 | msn.comSundowns take long term view on Olwethu MakhanyaMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)June 21, 2023 | msn.com13 of The Dumbest Childhood Trends We Can't Believe We DidJune 11, 2023 | msn.comRoughriders edge Elks 17-13 in season-opening road winJune 11, 2023 | msn.comUK to be hit with a month's worth of rain but will still be hotter than MonacoMarch 29, 2023 | msn.comLawmakers tour State Police Academy in New Braintree, tout recruitment fundingMarch 14, 2023 | msn.comLittle Bear's Big Trip - TrailerMay 4, 2024 | Banyan Hill Publishing (Ad)Forget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)March 14, 2023 | msn.comSon Accused Of Fatally Stabbing His Parents In South Jersey: ProsecutorMarch 7, 2023 | afr.comMacquarie Capital injects $150m into PE-owned IT services playerFebruary 7, 2023 | msn.comMasood calls for diplomacy to resolve Kashmir issueJanuary 22, 2023 | msn.comLeeds vs Brentford result: latest updates and live reaction to Premier League matchJanuary 22, 2023 | msn.comLeeds vs Brentford, Premier League live: Score and latest updatesDecember 12, 2022 | msn.comWhy The GMC Canyon Will Be Much More Expensive In 2023December 12, 2022 | msn.comMissouri Lottery player wins $50K after stop for gas in Kansas CitySeptember 25, 2022 | msn.comThe new youth-led Cardiff café that’s ‘better than Starbucks’September 8, 2022 | msn.comWhy There's So Much Confusion Surrounding Archie And Lilibet's New TitlesAugust 29, 2022 | msn.comNicki Minaj Performs for a Room Filled with BarbzAugust 23, 2022 | theglobeandmail.comBiggest stock winners from mammoth new U.S. spending bill. Plus, what a $4-billion dividend fund manager is buying and sellingSee More Headlines Receive CPXX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (CPXX) and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2016Today5/04/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CPXX CUSIPN/A CIK1327467 WebN/A Phone+1-609-2430123FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report CPXX Stock Analysis - Frequently Asked Questions How were (CPXX)'s earnings last quarter? (CPXX) (NASDAQ:CPXX) released its quarterly earnings results on Tuesday, May, 10th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.15) by $0.01. What other stocks do shareholders of (CPXX) own? Based on aggregate information from My MarketBeat watchlists, some companies that other (CPXX) investors own include Consolidated Water (CWCO), Anavex Life Sciences (AVXL), Alder Biopharmaceuticals (ALDR), SharkNinja (SN), Fc Global Realty (FCRE), Chipotle Mexican Grill (CMG), Immunomedics (IMMU), Arena Pharmaceuticals (ARNA) and VASCO Data Security International (VDSI). This page (NASDAQ:CPXX) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe asset beating inflation by 4xColonial MetalsHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (CPXX) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
